116 related articles for article (PubMed ID: 36369216)
1. Evaluation of serum soluble HLA-G levels post-recovery from COVID-19 and post-vaccination (Sinopharm and Pfizer-BioNTech).
Hamed RM; Mahmood MM; Ad'hiah AH
Hum Immunol; 2023 Feb; 84(2):71-74. PubMed ID: 36369216
[TBL] [Abstract][Full Text] [Related]
2. Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers.
Alqassieh R; Suleiman A; Abu-Halaweh S; Santarisi A; Shatnawi O; Shdaifat L; Tarifi A; Al-Tamimi M; Al-Shudifat AE; Alsmadi H; Al Sharqawi A; Alnawaiseh H; Anasweh Y; Domaidah FA; Jaber HA; Al-Zarir MR; Bsisu I
Vaccines (Basel); 2021 Oct; 9(11):. PubMed ID: 34835153
[TBL] [Abstract][Full Text] [Related]
3. Health Belief Model and parents' acceptance of the Pfizer-BioNTech and Sinopharm COVID-19 vaccine for children aged 5-18 years Old: A national survey.
Vatcharavongvan P; Boonyanitchayakul N; Khampachuea P; Sinturong I; Prasert V
Vaccine; 2023 Feb; 41(8):1480-1489. PubMed ID: 36707336
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Age, Gender and Comorbidities Upon SARS-CoV-2 Spike Antibody Induction After Two Doses of Sinopharm Vaccine and the Effect of a Pfizer/BioNtech Booster Vaccine.
Farid E; Herrera-Uribe J; Stevenson NJ
Front Immunol; 2022; 13():817597. PubMed ID: 35711448
[TBL] [Abstract][Full Text] [Related]
5. Qualitative Assessment of Early Adverse Effects of Pfizer-BioNTech and Sinopharm COVID-19 Vaccines by Telephone Interviews.
Abu-Halaweh S; Alqassieh R; Suleiman A; Al-Sabbagh MQ; AbuHalaweh M; AlKhader D; Abu-Nejem R; Nabulsi R; Al-Tamimi M; Alwreikat M; Alnouti M; Suleiman B; Yousef M; Jarbeh ME; Al-Shudifat AE; Alqassieh A; Bsisu I
Vaccines (Basel); 2021 Aug; 9(9):. PubMed ID: 34579187
[TBL] [Abstract][Full Text] [Related]
6. Soluble HLA-G is upregulated in serum of patients with severe COVID-19.
Al-Bayatee NT; Ad'hiah AH
Hum Immunol; 2021 Oct; 82(10):726-732. PubMed ID: 34304938
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Pfizer/BioNTech and Sinopharm COVID-19 vaccines in reducing hospital admissions in prince Hamza hospital, Jordan.
Al-Momani H; Aldajah K; Alda'ajah E; ALjafar Y; Abushawer Z
Front Public Health; 2022; 10():1008521. PubMed ID: 36211700
[TBL] [Abstract][Full Text] [Related]
8. The Severity of COVID-19 Affects the Plasma Soluble Levels of the Immune Checkpoint HLA-G Molecule.
Cordeiro JFC; Fernandes TM; Toro DM; da Silva-Neto PV; Pimentel VE; Pérez MM; de Carvalho JCS; Fraga-Silva TFC; Oliveira CNS; Argolo JGM; Degiovani AM; Ostini FM; Puginna EF; da Silva JS; Santos IKFM; Bonato VLD; Cardoso CRB; Dias-Baruffi M; Faccioli LH; Donadi EA; Sorgi CA; Fernandes APM; On Behalf Of The Immunocovid Study Group
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077133
[TBL] [Abstract][Full Text] [Related]
9. Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans - Five Veterans Affairs Medical Centers, United States, February 1-September 30, 2021.
Bajema KL; Dahl RM; Evener SL; Prill MM; Rodriguez-Barradas MC; Marconi VC; Beenhouwer DO; Holodniy M; Lucero-Obusan C; Brown ST; Tremarelli M; Epperson M; Mills L; Park SH; Rivera-Dominguez G; Morones RG; Ahmadi-Izadi G; Deovic R; Mendoza C; Jeong C; Schrag SJ; Meites E; Hall AJ; Kobayashi M; McMorrow M; Verani JR; Thornburg NJ; Surie D; ; ;
MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(49):1700-1705. PubMed ID: 34882654
[TBL] [Abstract][Full Text] [Related]
10. Humoral response to SARS-CoV-2 COVID-19 vaccines in patients with multiple sclerosis treated with immune reconstitution therapies.
Drulovic J; Ivanovic J; Martinovic V; Tamas O; Veselinovic N; Cujic D; Gnjatovic M; Mesaros S; Pekmezovic T
Mult Scler Relat Disord; 2021 Sep; 54():103150. PubMed ID: 34298478
[TBL] [Abstract][Full Text] [Related]
11. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
Self WH; Tenforde MW; Rhoads JP; Gaglani M; Ginde AA; Douin DJ; Olson SM; Talbot HK; Casey JD; Mohr NM; Zepeski A; McNeal T; Ghamande S; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Gong MN; Mohamed A; Henning DJ; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Exline MC; Halasa N; Chappell JD; Lauring AS; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Lindsell CJ; Hart KW; Zhu Y; Mills L; Lester SN; Stumpf MM; Naioti EA; Kobayashi M; Verani JR; Thornburg NJ; Patel MM;
MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1337-1343. PubMed ID: 34555004
[TBL] [Abstract][Full Text] [Related]
13. Detection of serum soluble HLA-G levels in patients with acute ischemic stroke: A pilot study.
Fainardi E; Bortolotti D; Castellazzi M; Casetta I; Bellini T; Rizzo R
Hum Immunol; 2020 Apr; 81(4):156-161. PubMed ID: 31735441
[TBL] [Abstract][Full Text] [Related]
14. HLA-G 14-bp insertion/deletion polymorphism and risk of coronavirus disease 2019 (COVID-19) among Iraqi patients.
Ad'hiah AH; Al-Bayatee NT
Hum Immunol; 2022 Jun; 83(6):521-527. PubMed ID: 35305830
[TBL] [Abstract][Full Text] [Related]
15. EVALUATION OF COVID-19 VACCINES EFFICACY IN IRAQI PEOPLES.
Jawad MJ; Jawad MJ; Hasan IS; Hassan SM; Fatima G; Hadi NR
Wiad Lek; 2022; 75(4 pt 2):929-937. PubMed ID: 35633320
[TBL] [Abstract][Full Text] [Related]
16. Post-vaccination outcomes in association with four COVID-19 vaccines in the Kingdom of Bahrain.
AlQahtani M; Du X; Bhattacharyya S; Alawadi A; Al Mahmeed H; Al Sayed J; Justman J; El-Sadr WM; Hidary J; Mukherjee S
Sci Rep; 2022 Jun; 12(1):9236. PubMed ID: 35654940
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
18. Increased sHLA-G Is Associated with Improved COVID-19 Outcome and Reduced Neutrophil Adhesion.
Bortolotti D; Gentili V; Rizzo S; Schiuma G; Beltrami S; Spadaro S; Strazzabosco G; Campo G; Carosella ED; Papi A; Rizzo R; Contoli M
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578436
[TBL] [Abstract][Full Text] [Related]
19. Detection of soluble HLA-G molecules in plasma and amniotic fluid.
Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H
Tissue Antigens; 1999 Jan; 53(1):14-22. PubMed ID: 10082427
[TBL] [Abstract][Full Text] [Related]
20. Demographic Characteristics and Status of Vaccinated Individuals with a History of COVID-19 Infection Pre- or Post-Vaccination: A Descriptive Study of a Nationally Representative Sample in Saudi Arabia.
AlRuthia Y; Al-Salloum HF; Almohammed OA; Alqahtani AS; Al-Abdulkarim HA; Alsofayan YM; Almudarra SS; AlQahtani SH; Almutlaq A; Alabdulkareem K; Balkhi B; Almutairi HT; Alanazi AS; Asiri YA
Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
